Search - tctmd.com

Displaying 881 - 900 of 2555

Sort: Relevancy | Date

News Conference News ESC 2018

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

Michael O'Riordan

August 25, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

Todd Neale

August 17, 2018

News Daily News

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

Michael O'Riordan

July 31, 2018

News Daily News

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Michael O'Riordan

July 23, 2018

News Daily News

Discharge Against Medical Advice After PCI Rare but Deadly

Michael O'Riordan

July 17, 2018

News Daily News

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Todd Neale

July 16, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Daily News

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

L.A. McKeown

July 10, 2018

News Daily News

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Caitlin E. Cox

June 28, 2018

Presentation The Structural Heart Disease Summit 2018

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

Presenter: Michael J. Mack, Raj Makkar

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

Presenter: Michael J. Mack, Raj Makkar, Maria Alu, MS

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Presenter: Michael J. Mack, Raj Makkar, Lars Sondergaard

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Presenter: Howard C. Herrmann, Fabian Nietlispach, Hasan Ahmad, MD

June 21, 2018

Presentation

Medium-Term Follow-Up of Early Leaflet Thrombosis After TAVR

June 20, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

VTE Risk Higher in Surgical Patients Who Get Transfusions

Todd Neale

June 13, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Daily News

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Yael L. Maxwell

June 08, 2018

Advertisement

MATRIX: 1-Year Results Confirm Superiority of Transradial PCI

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

ADAPT-DES: High On-Aspirin Platelet Reactivity Not Related to PCI Outcomes

New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI

No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT

Discharge Against Medical Advice After PCI Rare but Deadly

OCT, IVUS Each Boost Long-term Outcomes When Used to Guide PCI, Study Suggests

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis

Ultrathin-Strut DES Outperform Second-Gen DES at 1 Year: Meta-analysis

Should We Anticoagulate All Bioprosthetic Aortic Valves? Rationale, Ongoing Studies, and Recent Trends

New Guidelines and Classification of Bioprosthetic Valve Dysfunction and Failure: Implications and Thoughts on TAVR Durability

The Spectrum of Leaflet Thrombosis in Bioprosthetic Aortic Valves - Prevalence, Clinical Consequences, and Practical Management Strategies

Recurrent Leaflet Thrombosis After Sapien 3 Valve-in-Valve TAVR

Medium-Term Follow-Up of Early Leaflet Thrombosis After TAVR

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

VTE Risk Higher in Surgical Patients Who Get Transfusions

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

Platelet Reactivity Linked With Ischemic Stroke Risk Post-DES Implantation: ADAPT-DES Substudy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content